Interactions between Lipitor (atorvastatin) and antibiotics have been documented in medical literature. According to the prescribing information for Lipitor, the concomitant use of atorvastatin with certain antibiotics may increase the risk of myopathy or rhabdomyolysis, a serious condition that can cause muscle damage and kidney failure [1].
For example, the antibiotic rifampicin, used to treat tuberculosis, is a strong enzyme inducer that can decrease the levels of atorvastatin in the blood, potentially reducing its effectiveness. Conversely, the antibiotic clarithromycin, used to treat bacterial infections, is a strong inhibitor of the cytochrome P450 3A4 (CYP3A4) enzyme, which atorvastatin is metabolized by. This can increase the levels of atorvastatin in the blood, potentially increasing the risk of myopathy or rhabdomyolysis [2].
The interactions between Lipitor and antibiotics are often classified into different categories based on their effect on the risk of myopathy or rhabdomyolysis. For example, the antibiotics clarithromycin and erythromycin are known to increase the risk of myopathy or rhabdomyolysis when taken with atorvastatin, while the antibiotic rifampicin is known to decrease the risk [3].
It is essential for patients taking Lipitor to inform their healthcare provider about all medications, including antibiotics, to ensure safe and effective treatment. Patients should also be aware of the potential interactions between Lipitor and antibiotics and report any muscle pain, weakness, or signs of kidney problems to their healthcare provider immediately [4].
According to DrugPatentWatch.com [5], the patent for atorvastatin expired in 2011, allowing generic versions to enter the market.
Sources:
[1] http://www.accessdata.fda.gov/drugsatfdadocs/label/2006/021363s22lbl.pdf
[2] https://www.drugs.com/pro/atorvastatin.html
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941512/
[4] http://www.pfizer.com/products/product-detail/lipitor
[5] https://www.drugpatentwatch.com/DrugPatentDetails.aspx?GenericName=Atorvastatin
Sources:
1. http://www.accessdata.fda.gov/drugsatfdadocs/label/2006/021363s22lbl.pdf
2. https://www.drugs.com/pro/atorvastatin.html
3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941512/
4. http://www.pfizer.com/products/product-detail/lipitor
5. https://www.drugpatentwatch.com/DrugPatentDetails.aspx?GenericName=Atorvastatin